In short
Polycystic ovary syndrome (PCOS) is the most common hormonal condition in women of reproductive age, affecting 8–13% of women globally. At CLCC, care for PCOS/PCOD follows a five-step structured assessment: Assess, Identify, Reduce, Restore, Continue, addressing the systemic contributors alongside standard medical treatment, rather than symptom management alone.
What Is PCOS / PCOD
PCOS is not a disease of the ovaries, it is a metabolic disease that expresses through the ovaries.
Polycystic ovary syndrome (PCOS) is the most common hormonal condition in women of reproductive age, affecting 8–13% of women globally. It is characterised by irregular or absent menstrual cycles, elevated androgen levels producing excess facial and body hair, acne, and scalp hair thinning, and polycystic-appearing ovaries on ultrasound. These are the symptoms. The driver is metabolic.
Insulin resistance is the foundational mechanism in the majority of PCOS presentations. Elevated insulin directly stimulates androgen production in the ovarian theca cells, producing the excess androgens that drive the visible features of PCOS. Elevated insulin also suppresses sex hormone binding globulin (SHBG), increasing the fraction of free testosterone that is biologically active. The ovarian cysts, more accurately, arrested follicles, develop because the hormonal environment does not support normal follicular maturation and ovulation.
Addressing PCOS through oral contraceptive pills suppresses the hormonal expression, but does not correct the underlying insulin resistance. Symptoms return when medication is stopped. Treating PCOS through its metabolic root, dietary structure that reduces insulin demand, gut microbiome restoration that improves insulin sensitivity, stress-load reduction that reduces cortisol-mediated insulin dysregulation, and specific nutritional correction, produces sustainable improvement that persists because the underlying drivers, not just the expression, have been addressed.
CLCC builds every PCOS care plan around the specific metabolic and hormonal contributing factors identified in the patient's assessment, recognising that while insulin resistance is dominant in most, the relative contributions of stress load, gut dysfunction, nutritional deficiency, and thyroid health vary significantly between patients.
Symptoms
What pcos / pcod typically feels like.
Irregular menstrual cycles, longer than 35 days, or fewer than 9 periods per year
Absent periods (amenorrhoea) in more severe insulin resistance presentations
Excess facial and body hair (hirsutism), particularly chin, upper lip, chest, and abdomen
Scalp hair thinning or loss in a male pattern (androgenic alopecia)
Acne, particularly jawline, chin, and lower face, often adult-onset
Weight gain concentrated in the abdomen, central adiposity pattern
Difficulty losing weight despite dietary restriction
Skin tags and darkening of skin folds (acanthosis nigricans) in severe insulin resistance
Fertility difficulty, irregular ovulation producing unpredictable conception windows
Mood disturbance, anxiety and depression at significantly elevated rates in PCOS
Potential Contributing Factors
PCOS / PCOD is driven by more than hormones alone.
Understanding which factors are most active in your case is the purpose of the CLCC assessment. Each of the following can sustain hormonal imbalance independently.
Insulin resistance
The primary driver of androgen excess in most PCOS patients. Elevated insulin stimulates androgen production in the ovaries and suppresses SHBG, increasing free androgen activity. Correcting insulin resistance through dietary structure is the most effective PCOS intervention available.
Gut microbiome disruption
PCOS patients show altered gut microbiome composition compared to controls. Specific bacterial imbalances worsen insulin resistance and influence oestrogen metabolism through the gut-hormone axis. Gut restoration improves both insulin sensitivity and hormonal balance.
Chronic stress and cortisol
Cortisol dysregulation worsens insulin resistance and directly stimulates adrenal androgen production, producing a stress-PCOS interaction that is clinically significant in patients with high stress load. Stress management is a PCOS intervention, not an optional lifestyle recommendation.
Vitamin D deficiency
Vitamin D receptors are present in ovarian tissue and directly influence follicular development and insulin sensitivity. Vitamin D deficiency, extremely common in PCOS, worsens both the metabolic and reproductive dimensions of the condition. Therapeutic correction helps improve insulin sensitivity and menstrual regularity.
Thyroid dysfunction
Subclinical hypothyroidism worsens insulin resistance, impairs ovulation, and shares multiple features with PCOS. Thyroid status is assessed in every PCOS evaluation, the two conditions frequently coexist and each worsens the other.
Nutritional deficiencies
Chromium, magnesium, and inositol (specifically myo-inositol and D-chiro-inositol) are directly involved in insulin signalling and ovarian function. Their deficiency in PCOS patients contributes to both insulin resistance and impaired follicular maturation.
Impact on Daily Life
How pcos / pcod changes daily life.
→Fertility impact, irregular ovulation producing difficulty conceiving and uncertainty about reproductive timeline
→Significant body image distress from hirsutism, acne, hair loss, and weight gain
→Metabolic trajectory, untreated insulin resistance in PCOS carries significant long-term risk for type 2 diabetes and cardiovascular disease
→Psychological burden, rates of anxiety and depression are two to three times higher in PCOS than in the general female population
→Medication dependency, OCP suppresses symptoms without addressing the metabolic driver; stopping the pill returns symptoms without sustained benefit
→Difficulty navigating inconsistent medical advice, patients frequently told to 'lose weight' without the metabolic framework to explain why standard caloric restriction is ineffective in insulin-resistant PCOS
The CLCC Method: Five Steps Applied
Each step separate. Each specific to your hormonal profile.
Full metabolic and hormonal assessment, insulin first, not just androgens
Fasting insulin, HOMA-IR, HbA1c, lipid profile. Full hormonal panel, LH, FSH, testosterone, free testosterone, SHBG, DHEA-S, prolactin. Thyroid function. Vitamin D, magnesium, zinc. Gut health indicators. Stress load and cortisol pattern. Menstrual history and symptom timeline documented at baseline.
Map the specific PCOS profile, insulin-dominant, stress-dominant, gut-dominant, or mixed
The relative contribution of insulin resistance, stress-cortisol axis, gut dysfunction, and nutritional deficiency varies between patients. Lean PCOS differs from obese PCOS in its metabolic profile. The assessment differentiates these, determining the primary intervention emphasis.
Low-insulin dietary protocol as the primary intervention alongside targeted nutritional correction
A dietary protocol specifically designed to reduce insulin demand, not simply caloric restriction. Inositol supplementation for ovarian insulin signalling. Vitamin D3, chromium, magnesium, and zinc correction. Gut microbiome restoration. Stress-load reduction where stress axis is dominant.
Track hormonal markers, insulin sensitivity, and menstrual regularity at 3-month intervals
Fasting insulin, testosterone, SHBG, and menstrual pattern reviewed at structured intervals. Nutritional markers rechecked. Gut health assessed. Menstrual regularity, cycle length, presence of ovulation, is the primary functional outcome measure.
Long-term metabolic management, PCOS does not resolve without sustained lifestyle patterns
The metabolic dysfunction driving PCOS does not disappear, it is managed. The Continue phase maintains the dietary and lifestyle patterns that corrected insulin resistance, monitors metabolic markers annually, and provides structured support through reproductive life events, pregnancy planning, postpartum, perimenopause, where PCOS management requires adjustment.
Frequently Asked Questions
Questions patients ask about pcos / pcod care.
Is PCOS caused by the contraceptive pill?+
The OCP does not cause PCOS, but it can mask it. PCOS typically becomes apparent when the OCP is stopped and the underlying hormonal and metabolic pattern reasserts itself without pharmaceutical suppression. This is sometimes misinterpreted as the pill causing PCOS, but the condition was present, suppressed, during the time on the pill.
Can PCOS be managed without the OCP?+
Yes. The OCP manages PCOS symptoms by suppressing ovarian androgen production and regulating the menstrual cycle, but it does not address insulin resistance. Structured metabolic care through dietary correction, nutritional supplementation, and gut health restoration helps improve menstrual regularity, reduces androgen markers, and addresses the metabolic trajectory of PCOS, without hormonal suppression.
Can PCOS affect fertility?+
Yes, irregular ovulation makes conception unpredictable. Improving insulin resistance through structured metabolic care helps restore more regular ovulation in PCOS patients, improving natural conception probability. For patients pursuing assisted conception, metabolic correction improves IVF response and reduces miscarriage risk associated with the PCOS metabolic environment.
Does diet really matter that much in PCOS?+
Diet is the single most powerful modifiable intervention in PCOS, because the dietary pattern determines the insulin environment that drives androgen production. Specific dietary changes, reducing refined carbohydrates, eliminating excess fructose, timing meals appropriately, produce measurable reductions in fasting insulin within weeks that directly reduce androgen levels. No medication addresses the dietary driver of PCOS insulin resistance.
Is inositol useful for PCOS?+
Myo-inositol and D-chiro-inositol are insulin sensitisers that act directly on ovarian tissue. Clinical evidence for their use in PCOS is among the strongest in nutritional medicine for this condition, reducing insulin resistance, improving menstrual regularity, and reducing androgen markers. Therapeutic dosing and the appropriate ratio of the two inositol forms are assessed and prescribed as part of the CLCC PCOS care plan.